Wednesday, June 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “postoperative” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 75
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 75 pipeline programs matching "postoperative" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

75 results for “postoperative” Back to intelligence hub

Search results

Page 3 of 4
  1. Glycopyrronium in Combination With Tropisetron

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    approved small molecule completed

    1 trial
  2. HTX-011

    Heron Therapeutics

    Postoperative Pain

    approved small molecule completed

    8 trials
  3. Hydrocortisone Acetate 1% Ointment

    BRIGHT MINDS BIOSCIENCES INC.

    Postoperative Sore Throat, Cough, Hoarseness

    approved small molecule active

    1 trial
  4. Intraosseous Morphine

    Hospital Authority, Hong Kong

    Pain Postoperative

    approved other active

    1 trial
  5. Ketamine

    United Therapeutics Europe Ltd

    Chronic Postoperative Pain

    approved small molecule completed

    1 trial
  6. Liposomal Bupivacaine Infiltration

    Pacira Ireland Limited

    Postoperative Pain

    approved small molecule terminated

    1 trial
  7. Naldebain

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule active

    1 trial
  8. PALEXIA Retard 50 mg tabletten met verlengde afgifte

    Disc Medicine

    chronic postoperative pain

    approved small molecule active

    1 trial
  9. PCIA group

    The First People's Hospital of Lianyungang

    Postoperative Pain

    approved other active

    1 trial
  10. Parecoxib

    The First People's Hospital of Lianyungang

    Postoperative Pain Management, Pain Threshold, Shoulder Pain, Laparoscopies

    approved small molecule completed

    1 trial
  11. Pregabalin

    Vera Therapeutics

    Pain, Postoperative

    approved small molecule completed

    1 trial
  12. S-ketamine & Ropivacaine

    The First People's Hospital of Lianyungang

    Postoperative Analgesia

    approved small molecule active

    1 trial
  13. dexmedetomidine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    approved small molecule active

    1 trial
  14. preoperative 0.5% ropivacaine hydrochloride preoperative

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Pain

    approved small molecule completed

    1 trial
  15. propofol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Sleep Quality

    approved small molecule completed

    1 trial
  16. suzetrigine

    Vertex Pharmaceuticals (Australia) Pty.

    Pain, Acute Postoperative

    approved small molecule active

    1 trial
  17. valdecoxib

    Pfizer

    Pain, Postoperative

    approved small molecule completed

    1 trial
  18. Esketamine

    The First People's Hospital of Lianyungang

    Postoperative Cognitive Dysfunction

    small molecule completed

    1 trial
  19. Esketamine-lidocaine group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Chronic Pain

    small molecule active

    1 trial
  20. Etomidate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postoperative Complications

    small molecule completed

    1 trial
  21. Postoperative radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oral Tongue Squamous Cell Carcinoma

    other active

    1 trial
  22. Remifentanil

    Vera Therapeutics

    Postoperative Pain

    small molecule completed

    1 trial
  23. Ropivacaine

    Zealand Pharma A/S

    Pain, Postoperative

    small molecule terminated

    1 trial
  24. Sulfentanyl

    The First People's Hospital of Lianyungang

    Postoperative Nausea and Vomiting

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.